Mark Warne

Directeur Général chez DEEPMATTER GROUP PLC Fortune : 8 434 $ au 31/05/2026

Profil

Mark Robert Warne is Chief Executive Officer & Executive Director at ChemAI Ltd. since 2018, Non-Executive Chairman at Ixico Plc since 2016, Healthcare Portfolio Director at IP Group Plc, Non-Executive Director at hVIVO Services Ltd. since 2016, Director at DegraSense Ltd., Director at Genomics Ltd., Member of The Royal Society of Chemistry, and Advisor at Angelini Ventures SpA. Former roles include Chief Executive Officer & Director at Activiomics Ltd. from 2011 to 2013, Director at Azellon Ltd., Non-Executive Director at hVIVO Holdings Ltd., Managing Director at Receptor Research Ltd., Director at Capsant Neurotechnologies Ltd., Non-Executive Director at Crysalin Ltd., Director at Iksuda Therapeutics Ltd., Director at Ubiquigent Ltd., Non-Executive Director at Optimal Medicine Ltd., Independent Non-Executive Director at hVIVO PLC in 2020, and Head-Life Science Division at IP Group Plc.
Education includes undergraduate, graduate, and doctorate degrees from the University of Bristol.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
IXICO PLC 0,03 %	08/12/2025	72 335 ( 0,03 % )	8 434 $	31/05/2026

Postes actifs de Mark Warne

Sociétés	Poste	Début
DEEPMATTER GROUP PLC	Directeur Général	02/07/2018
IXICO PLC	Président	-
Angelini Ventures SpA	Consultant / Advisor	-
hVIVO Services Ltd.	Directeur/Membre du Conseil	01/04/2016
Genomics Plc	Directeur/Membre du Conseil	-
DegraSense Ltd.	Directeur/Membre du Conseil	-
The Royal Society of Chemistry	Corporate Officer/Principal	16/03/2011
IP Group Plc /Venture Capital/	Private Equity Investor	-

Anciens postes connus de Mark Warne

Sociétés	Poste	Fin
HVIVO PLC	Directeur/Membre du Conseil	31/12/2020
░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-